We are live on ! Find out more
FWP

Forward Pharma A/S American Depositary Shares

Delisted

FWP was delisted on the 27th of December, 2022.

35 hedge funds and large institutions have $292M invested in Forward Pharma A/S American Depositary Shares in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

30% more capital invested

Capital invested by funds: $225M → $292M (+$67M)

3% more funds holding

Funds holding: 3435 (+1)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
35
Holders Change
+1
Holders Change %
+2.94%
% of All Funds
0.93%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
12
Increased
12
Reduced
7
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BG
1
Baupost Group
Massachusetts
$152M
BI
2
BVF Inc
California
$33.3M +$2.9M +17,872 +12%
O
3
OrbiMed
New York
$27.2M
Franklin Resources
4
Franklin Resources
California
$8.5M
CAM
5
Cormorant Asset Management
Massachusetts
$7.22M +$2.43M +15,000 +70%
AIM
6
Assured Investment Management
New York
$6.79M +$5.55M +34,234 New
Goldman Sachs
7
Goldman Sachs
New York
$6.42M +$173K +1,067 +3%
HJMC
8
Hellman Jordan Management Company
Massachusetts
$5.96M +$857K +5,283 +21%
WC
9
Wexford Capital
Florida
$5.88M -$32.1K -198 -0.7%
SFM
10
Sphera Funds Management
Israel
$5.1M -$464K -2,857 -10%
EC
11
EcoR1 Capital
California
$4.5M +$1.37M +8,426 +59%
Millennium Management
12
Millennium Management
New York
$4.27M +$3.49M +21,520 New
Fidelity Investments
13
Fidelity Investments
Massachusetts
$4.05M
GCM
14
Gruss Capital Management
New York
$3.54M +$2.9M +17,857 New
MIM
15
Monashee Investment Management
Massachusetts
$2.83M +$2.32M +14,286 New
Alyeska Investment Group
16
Alyeska Investment Group
Illinois
$2.75M +$66.4K +409 +3%
SM
17
Sabby Management
Florida
$2.55M +$2.09M +12,866 New
SCM
18
Sio Capital Management
New York
$1.91M -$961K -5,923 -38%
BG
19
BlackRock Group
United Kingdom
$1.75M -$1.42M -8,760 -50%
Citadel Advisors
20
Citadel Advisors
Florida
$1.26M -$15.3K -94 -1%
Point72 Asset Management
21
Point72 Asset Management
Connecticut
$1.19M +$975K +6,007 New
Morgan Stanley
22
Morgan Stanley
New York
$641K +$276K +1,703 +111%
BACM
23
Blue Arrow Capital Management
New York
$425K +$348K +2,143 New
RCM
24
Rotella Capital Management
Washington
$413K +$338K +2,086 New
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
$407K +$333K +2,054 New

FWP Hedge Fund Activity: Q1 2015 in Review

35 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q1 2015, worth a combined $292M — up 30% from $225M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new FWP positions and 11 closed out — a net gain of 1 holder — while 12 added to existing stakes and 7 trimmed.

The largest buyer was Assured Investment Management, opening a new position worth an estimated $5.55M. The largest seller was RA Capital Management, exiting entirely with an estimated $20.2M sold.

  • 35 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q1 2015, up from 34 in Q4 2014.
  • Funds reported $292M of Forward Pharma A/S American Depositary Shares stock for Q1 2015, up 30% quarter-over-quarter.
  • 12 funds opened new Forward Pharma A/S American Depositary Shares positions in Q1 2015 and 11 closed out, a net change of +1 holder.
  • The largest Forward Pharma A/S American Depositary Shares buyer in Q1 2015 was Assured Investment Management, an estimated $5.55M added.
  • The largest Forward Pharma A/S American Depositary Shares seller in Q1 2015 was RA Capital Management, an estimated $20.2M sold.

Based on aggregated 13F filings for Q1 2015.